Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine on spirometry in hemodialysis
IRCT20161219031464N3Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levocarnitine in end-stage kidney disease (ESKD), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Ergospirometric test results. Started Oct 2016; status: completed.
02
Drugs
levocarnitine
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT20161219031464N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161219031464N3.